InVitro International, Inc. (IVRO)
OTCMKTS · Delayed Price · Currency is USD
0.0700
0.00 (0.00%)
At close: Nov 9, 2026
InVitro International Revenue
In the fiscal year ending September 30, 2025, InVitro International had annual revenue of $878.94K with 8.34% growth. InVitro International had revenue of $213.39K in the quarter ending September 30, 2008, with 84.11% growth. That makes InVitro International the 43,823rd largest company in the world by revenue and 6,143rd in the United States.
Revenue
878.94K
Revenue Growth
-12.40%
P/S Ratio
1.77
Revenue / Employee
175.79K
Employees
5
Market Cap
1.56M
Revenue by Geography
- United States 520.71K 59.2%
- Other Countries 358.23K 40.8%
Fiscal year ended Sep 30, 2025 See the full InVitro International breakdown
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Sep 30, 2025 | 878.94K | 67.65K | 8.34% |
| Sep 30, 2024 | 811.29K | 18.66K | 2.35% |
| Sep 30, 2023 | 792.63K | -60.88K | -7.13% |
| Sep 30, 2022 | 853.51K | -149.89K | -14.94% |
| Sep 30, 2021 | 1.00M | -101.41K | -9.18% |
| Sep 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Bioqual | 40.24M |
| Psychemedics | 19.69M |
| Aspira Women's Health | 8.55M |
| Medical Imaging | 7.52M |
| ProPhase Labs | 3.85M |
| IDenta | 1.86M |
| Longduoduo Company | 1.82M |
| NovelStem International | 3.00K |
InVitro International News
- 3 months ago - A Brighter Future Is on the Way - Newsfile Corp
- 6 months ago - Continuing the Cause; Humane Global Animal Welfare - Newsfile Corp
- 11 months ago - Game Changing Signals from Global Regulatory Agencies Accompany IVRO Sales and Profit Gains - Newsfile Corp
- 1 year ago - IVRO's Q3 Packed with Positives; Sales, Profits, and U.S. Government/Global Support for Animal Welfare - Newsfile Corp
- 1 year ago - IVRO Announces Strong FY '25 First Quarter Sales & Net Income Advances - Newsfile Corp
- 1 year ago - IVRO Signs MOU to Merge With a European Based Non-Animal Testing Focused Organization - Newsfile Corp
- 1 year ago - InVitro International: Expectations Remain High for Animal Welfare & Growth Opportunities - Newsfile Corp
- 2 years ago - InVitro International Engages Askew Kabala and Company, Inc. to Further Advance Its Corporate Growth Plan - Newsfile Corp